Adult Malignant Glioma Therapeutics Market to Reach US$ 2,964.5 Mn by 2026, High Prevalence of Glioma in Adults to Enable Growth
The Global Adult Malignant Glioma Therapeutics Market is likely to grow in the coming years due to advancements made in targeted therapy to treat malignant glioma. According to a report published by Fortune Business Insights, titled "Adult Malignant Glioma Therapeutics: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 1,459.1 Mn. Fortune Business Insights states that the market is likely to reach US$ 2,964.5 Mn at a CAGR of 9.3% in the forecast period.
View full press release